Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

1.

Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus.

Dunkler D, Dehghan M, Teo KK, Heinze G, Gao P, Kohl M, Clase CM, Mann JF, Yusuf S, Oberbauer R; ONTARGET Investigators.

JAMA Intern Med. 2013 Oct 14;173(18):1682-92.

PMID:
23939297
[PubMed - indexed for MEDLINE]
2.

[Blood glucose control during cardiac surgery. Report of the Emergency Council of the Argentine Society of Cardiology].

Benzadón MN, Cohen Arazi H, Comignani P, Villareal R, Trivi M, Fuselli JJ, Blanco P; Consejo de Emergencias de la Sociedad Argentina de Cardiología.

Medicina (B Aires). 2012;72(1):58-62. Spanish.

PMID:
22257460
[PubMed - indexed for MEDLINE]
3.

RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome.

Steg PG, Mehta SR, Jukema JW, Lip GY, Gibson CM, Kovar F, Kala P, Garcia-Hernandez A, Renfurm RW, Granger CB; RUBY-1 Investigators.

Eur Heart J. 2011 Oct;32(20):2541-54. doi: 10.1093/eurheartj/ehr334. Epub 2011 Aug 30.

PMID:
21878434
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome.

Weber M, Bazzino O, Navarro Estrada JL, de Miguel R, Salzberg S, Fuselli JJ, Liebetrau C, Woelken M, Moellmann H, Nef H, Hamm C.

Am Heart J. 2011 Jul;162(1):81-8. doi: 10.1016/j.ahj.2011.04.007.

PMID:
21742093
[PubMed - indexed for MEDLINE]
5.

Unrecognised ventricular dysfunction in COPD.

Macchia A, Rodriguez Moncalvo JJ, Kleinert M, Comignani PD, Gimeno G, Arakaki D, Laffaye N, Fuselli JJ, Massolin HP, Gambarte J, Romero M, Tognoni G.

Eur Respir J. 2012 Jan;39(1):51-8. doi: 10.1183/09031936.00044411. Epub 2011 Jun 23.

PMID:
21700606
[PubMed - indexed for MEDLINE]
Free Article
6.

Rationale, design, and results from RENO-DEFEND 1: a randomized, dose-finding study of the selective A1 adenosine antagonist SLV320 in patients hospitalized with acute heart failure.

Pang PS, Mehra M, Maggioni AP, Filippatos G, Middlebrooks J, Turlapaty P, Kazei D, Gheorghiade M; RENO-DEFEND Investigators.

Am Heart J. 2011 Jun;161(6):1012-23.e3. doi: 10.1016/j.ahj.2011.03.004.

PMID:
21641345
[PubMed - indexed for MEDLINE]
7.

Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.

CURRENT-OASIS 7 Investigators, Mehta SR, Bassand JP, Chrolavicius S, Diaz R, Eikelboom JW, Fox KA, Granger CB, Jolly S, Joyner CD, Rupprecht HJ, Widimsky P, Afzal R, Pogue J, Yusuf S.

N Engl J Med. 2010 Sep 2;363(10):930-42. doi: 10.1056/NEJMoa0909475. Erratum in: N Engl J Med. 2010 Oct 14;363(16):1585.

PMID:
20818903
[PubMed - indexed for MEDLINE]
Free Article
8.

Anemia and chronic heart failure: from pathophysiologic mechanisms to clinical trial designs.

Macchia A, Mariani J, Comignani PD, Fuselli JJ, Monte S, Romero M, Tognoni G.

Expert Rev Cardiovasc Ther. 2009 Feb;7(2):139-45. doi: 10.1586/14779072.7.2.139. Review.

PMID:
19210210
[PubMed - indexed for MEDLINE]
9.

Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.

Tardif JC, Ponikowski P, Kahan T; ASSOCIATE Study Investigators.

Eur Heart J. 2009 Mar;30(5):540-8. doi: 10.1093/eurheartj/ehn571. Epub 2009 Jan 9.

PMID:
19136486
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Hypertensive urgencies in the emergency department: evaluating blood pressure response to rest and to antihypertensive drugs with different profiles.

Grassi D, O'Flaherty M, Pellizzari M, Bendersky M, Rodriguez P, Turri D, Forcada P, Ferdinand KC, Kotliar C; Group of Investigators of the REHASE Program.

J Clin Hypertens (Greenwich). 2008 Sep;10(9):662-7. doi: 10.1111/j.1751-7176.2008.00001.x.

PMID:
18844760
[PubMed - indexed for MEDLINE]
11.

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Fox K, Ford I, Steg PG, Tendera M, Ferrari R; BEAUTIFUL Investigators.

Lancet. 2008 Sep 6;372(9641):807-16. doi: 10.1016/S0140-6736(08)61170-8. Epub 2008 Aug 29.

PMID:
18757088
[PubMed - indexed for MEDLINE]
12.

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.

Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators, Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P.

Lancet. 2008 Sep 27;372(9644):1174-83. doi: 10.1016/S0140-6736(08)61242-8. Epub 2008 Aug 29. Erratum in: Lancet. 2008 Oct 18;372(9647):1384.

PMID:
18757085
[PubMed - indexed for MEDLINE]
13.

The BEAUTIFUL study: randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction - baseline characteristics of the study population.

Beautiful Study Group, Ferrari R, Ford I, Fox K, Steg PG, Tendera M.

Cardiology. 2008;110(4):271-82.

PMID:
18595216
[PubMed - indexed for MEDLINE]
14.

Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial.

Yancy CW, Krum H, Massie BM, Silver MA, Stevenson LW, Cheng M, Kim SS, Evans R; FUSION II Investigators.

Circ Heart Fail. 2008 May;1(1):9-16. doi: 10.1161/CIRCHEARTFAILURE.108.767483.

PMID:
19808265
[PubMed - indexed for MEDLINE]
Free Article
15.

Telmisartan, ramipril, or both in patients at high risk for vascular events.

ONTARGET Investigators, Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C.

N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31.

PMID:
18378520
[PubMed - indexed for MEDLINE]
Free Article
16.

N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.

Weber M, Bazzino O, Navarro Estrada JL, Fuselli JJ, Botto F, Perez de Arenaza D, Möllmann H, Nef HN, Elsässer A, Hamm CW.

J Am Coll Cardiol. 2008 Mar 25;51(12):1188-95. doi: 10.1016/j.jacc.2007.11.054.

PMID:
18355657
[PubMed - indexed for MEDLINE]
Free Article
17.

Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes.

Bazzino O, Fuselli JJ, Botto F, Perez De Arenaza D, Bahit C, Dadone J; PACS group of investigators.

Eur Heart J. 2004 May;25(10):859-66.

PMID:
15140534
[PubMed - indexed for MEDLINE]
Free Article
18.

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Køber L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM; Valsartan in Acute Myocardial Infarction Trial Investigators.

N Engl J Med. 2003 Nov 13;349(20):1893-906. Epub 2003 Nov 10. Erratum in: N Engl J Med. 2004 Jan 8;350(2):203.

PMID:
14610160
[PubMed - indexed for MEDLINE]
Free Article
19.

First national survey on management strategies in non ST-elevation acute ischaemic syndromes in Argentina. Results of the STRATEG-SIA study.

Ferreirós ER, Kevorkian R, Fuselli JJ, Guetta J, Boissonnet CP, di Toro D, Cragnolino R, Masoli O, Cagide A, Krauss J; STRATEG-SIA Study Investigators and of the Sociedad Argentina de Cardiología.

Eur Heart J. 2002 Jul;23(13):1021-9.

PMID:
12093054
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk